JPS59204175A - 5―フルオロウラシル誘導体を有効成分とする血小板凝集抑制剤 - Google Patents
5―フルオロウラシル誘導体を有効成分とする血小板凝集抑制剤Info
- Publication number
- JPS59204175A JPS59204175A JP58075427A JP7542783A JPS59204175A JP S59204175 A JPS59204175 A JP S59204175A JP 58075427 A JP58075427 A JP 58075427A JP 7542783 A JP7542783 A JP 7542783A JP S59204175 A JPS59204175 A JP S59204175A
- Authority
- JP
- Japan
- Prior art keywords
- fluorouracil
- fatty acid
- higher fatty
- platelet aggregation
- cancer metastasis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP58075427A JPS59204175A (ja) | 1983-04-28 | 1983-04-28 | 5―フルオロウラシル誘導体を有効成分とする血小板凝集抑制剤 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP58075427A JPS59204175A (ja) | 1983-04-28 | 1983-04-28 | 5―フルオロウラシル誘導体を有効成分とする血小板凝集抑制剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS59204175A true JPS59204175A (ja) | 1984-11-19 |
| JPH0368845B2 JPH0368845B2 (enExample) | 1991-10-30 |
Family
ID=13575896
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP58075427A Granted JPS59204175A (ja) | 1983-04-28 | 1983-04-28 | 5―フルオロウラシル誘導体を有効成分とする血小板凝集抑制剤 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS59204175A (enExample) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6258836B1 (en) | 1988-02-26 | 2001-07-10 | Protarga, Inc. | Dopamine analog amide |
| US6576636B2 (en) | 1996-05-22 | 2003-06-10 | Protarga, Inc. | Method of treating a liver disorder with fatty acid-antiviral agent conjugates |
| US6602902B2 (en) | 1996-05-22 | 2003-08-05 | Protarga, Inc. | Dha-pharmaceutical agent conjugates to improve tissue selectivity |
| US7235583B1 (en) | 1999-03-09 | 2007-06-26 | Luitpold Pharmaceuticals, Inc., | Fatty acid-anticancer conjugates and uses thereof |
| JP2008540393A (ja) * | 2005-05-04 | 2008-11-20 | プロノヴァ バイオファーマ ノルゲ アクティーゼルスカブ | 新規化合物 |
| US8399516B2 (en) | 2006-11-01 | 2013-03-19 | Pronova Biopharma Norge As | Alpha-substituted omega-3 lipids that are activators or modulators of the peroxisome proliferators-activated receptor (PPAR) |
| JP2013216668A (ja) * | 2005-05-04 | 2013-10-24 | Pronova Biopharma Norge As | 新規化合物 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5186480A (en) * | 1975-01-22 | 1976-07-29 | Asahi Chemical Ind | 55 furuororashirujudotainoseiho |
-
1983
- 1983-04-28 JP JP58075427A patent/JPS59204175A/ja active Granted
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5186480A (en) * | 1975-01-22 | 1976-07-29 | Asahi Chemical Ind | 55 furuororashirujudotainoseiho |
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6258836B1 (en) | 1988-02-26 | 2001-07-10 | Protarga, Inc. | Dopamine analog amide |
| US6407137B2 (en) | 1988-02-26 | 2002-06-18 | Protarga, Inc. | Dopamine analog amide |
| US6576636B2 (en) | 1996-05-22 | 2003-06-10 | Protarga, Inc. | Method of treating a liver disorder with fatty acid-antiviral agent conjugates |
| US6602902B2 (en) | 1996-05-22 | 2003-08-05 | Protarga, Inc. | Dha-pharmaceutical agent conjugates to improve tissue selectivity |
| US7199151B2 (en) | 1996-05-22 | 2007-04-03 | Luitpold Pharmaceuticals, Inc. | DHA-pharmaceutical agent conjugates of taxanes |
| US7235583B1 (en) | 1999-03-09 | 2007-06-26 | Luitpold Pharmaceuticals, Inc., | Fatty acid-anticancer conjugates and uses thereof |
| JP2008540393A (ja) * | 2005-05-04 | 2008-11-20 | プロノヴァ バイオファーマ ノルゲ アクティーゼルスカブ | 新規化合物 |
| JP2013216668A (ja) * | 2005-05-04 | 2013-10-24 | Pronova Biopharma Norge As | 新規化合物 |
| US8618165B2 (en) | 2005-05-04 | 2013-12-31 | Pronova Biopharma Norge As | Compounds |
| US8399516B2 (en) | 2006-11-01 | 2013-03-19 | Pronova Biopharma Norge As | Alpha-substituted omega-3 lipids that are activators or modulators of the peroxisome proliferators-activated receptor (PPAR) |
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0368845B2 (enExample) | 1991-10-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0388188B1 (en) | Benzoxepin derivatives | |
| JPH0368845B2 (enExample) | ||
| CN109970558B (zh) | 西柏三烯-4-醇-6-羧酸酯及其制备方法和应用 | |
| JPWO1991003471A1 (ja) | アスコルビン酸誘導体 | |
| US3870792A (en) | Certain dihydrophthalizines for treating hemorrhage and thrombosis | |
| JPS6155911B2 (enExample) | ||
| JPH0560478B2 (enExample) | ||
| JPS637558B2 (enExample) | ||
| US3751408A (en) | Imidazole-ribosyl cyclophosphate compounds and therapeutic compositions | |
| JPH04368359A (ja) | カプサイシン誘導体又はその酸エステルを有効成分とする鎮痛剤、血管拡張剤 | |
| JP3103935B2 (ja) | カルシウム拮抗剤 | |
| JPS62174060A (ja) | 5−フルオロウラシル誘導体およびこれを含有する医薬製剤 | |
| JPS6183125A (ja) | 癌転移阻害剤 | |
| JPS632546B2 (enExample) | ||
| JPS5967264A (ja) | 血小板凝集抑制剤 | |
| JPS60228414A (ja) | 12−リポキシゲナ−ゼ代謝産物に起因する疾患の予防治療剤 | |
| JPH0730000B2 (ja) | 新規ド−パミン誘導体、該誘導体を有効成分とする血小板凝集抑制剤および5−リポキシゲナ−ゼ阻害剤 | |
| JPH0368844B2 (enExample) | ||
| JPS5967275A (ja) | 5−フルオロウラシル誘導体およびその製法 | |
| JPS59110682A (ja) | 5―フルオロウラシル誘導体を有効成分とする血小板凝集抑制剤 | |
| JPS6087272A (ja) | 5―フルオロウラシル誘導体を有効成分とする血小板凝集抑制剤 | |
| JPS6115A (ja) | リポキシゲナ−ゼ代謝産物に起因する疾患の予防治療剤 | |
| JPH03294224A (ja) | 抗腫瘍剤 | |
| JPS5967263A (ja) | ペンタエン高級脂肪酸ピリジルアルコ−ルエステルおよびその製法 | |
| JPS61277617A (ja) | 坑血小板凝集剤 |